Twist Bioscience Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Twist Bioscience's inventory turnover ratio sequentially decreased to 6.5 in the second quarter 2026, otherwise the ratio remained above the average, as TWST's markets remain strong.Twist Bioscience's average inventory processing period in the Mar 31 2026 quarter, has increased to 56 days, from 52 days, in the Dec 31 2025 quarter.

Within Healthcare sector 57 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 404, from total ranking in the first quarter 2026 at 445.

TWST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Twist Bioscience Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TWST Inventory Turnover Ratio	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter	(Mar 31 2025) II. Quarter
Y / Y Inventory Growth	60.67 %	39.99 %	17.57 %	-8.94 %	-31.33 %
Y / Y Cost of Sales Growth	14.6 %	8.4 %	3.65 %	-3.1 %	5.28 %
Inventory Turnover Ratio (TTM)	6.5	7.01	7.53	7.79	7.65
TWST's Total Ranking	# 404	# 445	# 445	# 197	# 169
Average inventory processing period	56	52	48	47	48
Seq. Inventory Growth	1.8 %	16.3 %	9.14 %	24.34 %	-11.3 %
Seq. Cost of Sales Growth	7.78 %	3.23 %	7.62 %	-4.29 %	1.94 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 5
Healthcare Sector	# 58
Overall Market	# 404

Inventory Turnover Ratio Statistics
High	Average	Low
8.31	5.03	0.56
(Sep 30 2019)		(Dec 31 2018)

TWST Company Profile >> Back to TWST Efficiency Comparisons >> Compare TWST Inventory Turnover Ratio to its Competitors

Financial Statements
Twist Bioscience's Inventories	$ 34 Millions	Visit TWST's Balance sheet
Twist Bioscience's Cost of Revenues TTM	$ 196 Millions	Visit TWST's Income Statement
What are TWST's Sales?		Visit TWST's Sales by Segment

Other Inventory Turnover Ratios
Twist Bioscience's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TWST's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TWST's Competitors
Inventory Turnover Ratio for TWST's Suppliers
Inventory Turnover Ratio for TWST's Customers

You may also want to know
TWST's Sales Growth Rates	TWST's Pe Price to earnings ratio	TWST's Receivables Turnover Ratio	TWST's Stock Quote
TWST's Net Income Growth Rates	TWST's Ps Price to Sales ratio	TWST's Sales per Employee	TWST's Asset Turnover Ratio
TWST's Net Margin	TWST's Pb Price to Book ratio	TWST's Financial Strength Ratios	TWST's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Precipio inc	15.93	$ 14.540 Millions	$ 1 Millions
Rockwell Medical inc	15.34	$ 56.000 Millions	$ 4 Millions
Aurinia Pharmaceuticals Inc	14.12	$ 30.596 Millions	$ 2 Millions
Star Equity Holdings Inc	13.78	$ 106.877 Millions	$ 8 Millions
Natera Inc	13.48	$ 869.958 Millions	$ 65 Millions
Cryo cell International Inc	13.44	$ 7.049 Millions	$ 1 Millions
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
Tarsus Pharmaceuticals Inc	9.09	$ 37.864 Millions	$ 4 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.986 Millions	$ 0 Millions

Date modified: 2026-08-30T14:58:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.